NEW YORK and MONTREAL, Feb. 1 /PRNewswire-FirstCall/ - ICBS Ltd. (OTCPK: ICBT), announced today that it has taken delivery of the new TOGS(TM) 3000 bio-photonic incubation & detection systems, which the company will be marketing in the U.S. and overseas. The TOGS(TM) 3000 has 100% accuracy in the detection of Total Coli forms and E. Coli bacteria in water.
"BioSpec Global Solutions will be moving to introduce the new TOGS(TM) 3000 in the U.S, and overseas." said Don Saunders, President and CEO. "Given the advantages on processing time (24 hours) plus the accuracy of these machines, (100%), can equip people with the technology needed to insure safe drinking water ."
The TOGS(TM) 3000 has been verified by Ryerson University, Agriculture Canada and Saskatchewan Department of Health. It has been accepted for use for drinking water analysis by EPA in the USA when used in conjunction with our EPA approved reagent and method,. The TOGS(TM) 3000 has been used in a research project by the World Health Organization in Hawaii and by OCETA in India. Agents and distributors are being established to set up a global marketing network. Further verification and validation studies will be done shortly by users and ETV (Environmental Technology Verification) for microbial quantification for beach and wastewater applications.
The timing for commercialization is excellent. The World Health Organization has declared "safe drinking water is a human right" and the United Nations is struggling with its mandate to protect drinking water quality in over 100 million wells worldwide. Governments of the world are being pressured to conform to these directives. World pressure on China over food and water safety is presently a good example of that. BioSpec Global Solutions is currently in talks with a Chinese distributor.
The company holds worldwide patents on the TOGS(TM) 3000 and TOGS9000.(TM)
NB. This news release includes statements that constitute forward-looking statements. Please be aware that any such forward-looking statements are not guarantees of future performance and involve significant risks and uncertainties, and that actual results may vary materially from those in the forward-looking statements as a result of any number of factors, including the risk factors contained in the Company's disclosure documents.
SOURCE BioSpec Global Solutions Inc.
|SOURCE BioSpec Global Solutions Inc.|
Copyright©2010 PR Newswire.
All rights reserved